Floatz logo

SIMVASTATIN

Acute Ischemic Stroke

Prof. dr. Nathalie van der VeldeSmall moleculePhase 4 / ApprovedActive
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
64/ 100
Competitive Position
65/ 100

Competitive context

106 Active assets in the Acute Ischemic Stroke cohort.

Asset / SponsorPhaseRating
Compound Edaravone
Nanfang Hospital, Southern Medical University
Phase 4BBB
Tenecteplase
Hackensack Meridian Health
Phase 4BBB
3-N-BUTYLPHTHALIDE
Nanfang Hospital, Southern Medical University
Phase 4BBB
Tirofiban
Weifang Medical University
Phase 4BB
Nicardipine
Haseki Training and Research Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

SIMVASTATIN is also rated in:

HypercholesterolemiaDormant
BBB
Indicative ·
76 / 100
View asset →
psychotic disorderDormant
BBB
Indicative ·
75 / 100
View asset →
inherited lipid metabolism disorderDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →